HDAC1 and triple-negative breast carcinoma: These two compounds have IC50 values for HDAC1 and HDAC2 higher than 10 μM, and compound 6 showed in vitro efficacy in suppressing the cancer stem cell subpopulation of triple-negative breast cancer by downregulating β-catenin [61].